Current status of advance care planning, palliative care consultation, and end-of-life care in patients with glioblastoma in South Korea.

ABSTRACT:

Background

Given the typical trajectory of glioblastoma, many patients lose decision-making capacity over time, which can lead to inadequate advance care planning (ACP) and end-of-life (EOL) care. We aimed to evaluate patients' current ACP and EOL care status.

Patients and methods

We conducted a cohort study on 205 patients referred to oncologists at a Korean tertiary hospital between 2017 and 2022. We collected information on sociodemographic factors, cancer treatment, palliative care consultation, ACP, legal documents on life-sustaining treatment (LST) decisions, and aggressiveness of EOL care.

Results

With a median follow-up time of 18.3 months: 159 patients died; median overall survival: 20.3 months. Of the 159 patients, 11 (6.9%) and 63 (39.6%) had advance direct

SUBMITTER: Suh KJ 

PROVIDER: S-EPMC11546624 | biostudies-literature | 2024 Nov

REPOSITORIES: biostudies-literature